Webcast CME

Basic and Clinical Immunology Webcast Series



IMIDs Advances in Disease Pathogenesis

Print this Content

Release Date:   May 9, 2018
Expiration Date:   May 9, 2020

Estimated Time of Completion:   30 minutes

Description

Basic and Clinical Immunology series provides clinicians with a review of basic and clinical immunology. It is comprised of A-B-C teaching with an emphasis on biologic principles and implications and focuses on three areas- basic overview of immunology, a review of current advances, and biologic therapies for IMIDS.

This webcast will review immunomodulatory drugs and their ever changing landscape as well the advances in disease pathogenesis.

Learning Objectives

  1. Define the nature of immunomodulatory drugs (IMIDs) and their changing landscape.
  2. Highlight a variety of C5 and IL-5 targets.
  3. Discuss IMIDs in diseases that cross out of the world of immunology and inflammation.

Target Audience

This activity is directed to rheumatologists, dermatologists, gastroenterologists, allergists, clinical immunologists, and specialists in infectious disease, integrative medicine, primary care and other health care professionals caring for patients with immunologic diseases.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Director and Faculty

Activity Director

Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Faculty

William Rigby, MD
Vice-Chair, Department of Medicine
Professor of Medicine and Microbiology
The Geisel School of Medicine at Dartmouth
Lebanon, NH

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:


Leonard Calabrese, DO
  AbbVie Pharmaceuticals, Bristol-Myers Squibb Co, Genentech/Roche, Janssen Consulting; Teaching and Speaking
  Crescendo Teaching and Speaking
  GlaxoSmithKine, Pfizer, Regeneron, Sanofi Aventis UCB, Inc. Consulting
William Rigby, MD
  Abbott Laboratories Independent contractor (including contracted research); Teaching and Speaking
  Bristol-Myers Squibb Co. Consulting
  Eli Lilly Consulting; Membership on advisory committee or review panels
  Genentech/Roche Consulting; Independent contractor (including contracted research); Membership on advisory committee or review panels; Teaching and Speaking
  Pfizer Membership on advisory committee or review panels

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Internet Enduring activity from:

AbbVie, Inc.
Bristol-Myers Squibb
Genentech
Janssen Scientific Affairs, LLC
Lilly USA, LLC


The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Live activity from:

AbbVie, Inc.
Bristol-Myers Squibb
Genentech
Genzyme Corporation
Janssen Scientific Affairs, LLC
Lilly USA, LLC
Pfizer

This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education
and the R.J. Fasenmyer Center for Clinical Immunology.